[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

US20020066748A1 - Hermetically sealed container with medicament storing and dispensing insert - Google Patents

Hermetically sealed container with medicament storing and dispensing insert Download PDF

Info

Publication number
US20020066748A1
US20020066748A1 US09/731,128 US73112800A US2002066748A1 US 20020066748 A1 US20020066748 A1 US 20020066748A1 US 73112800 A US73112800 A US 73112800A US 2002066748 A1 US2002066748 A1 US 2002066748A1
Authority
US
United States
Prior art keywords
container
plunger
membrane
medicament
pocket
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/731,128
Other versions
US6387073B1 (en
Inventor
Gerhard Weiler
Frank Leo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Catalent Pharma Solutions LLC
Weiler Engineering Inc
Catalent Pharma Solutions Inc
Catalent USA Woodstock Inc
Catalent USA Paintball Inc
Catalent USA Packaging LLC
Original Assignee
Automatic Liquid Packaging Inc
Weiler Engineering Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Automatic Liquid Packaging Inc, Weiler Engineering Inc filed Critical Automatic Liquid Packaging Inc
Priority to US09/731,128 priority Critical patent/US6387073B1/en
Assigned to AUTOMATIC LIQUID PACKAGING, INC. reassignment AUTOMATIC LIQUID PACKAGING, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LEO, FRANK N.
Assigned to WEILER ENGINEERING, INC. reassignment WEILER ENGINEERING, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WEILER, GERHARD H.
Priority to JP2002547569A priority patent/JP2004515279A/en
Priority to CA002430715A priority patent/CA2430715C/en
Priority to MXPA03005089A priority patent/MXPA03005089A/en
Priority to PCT/US2001/046384 priority patent/WO2002045789A1/en
Priority to AT01989899T priority patent/ATE439824T1/en
Priority to EP01989899A priority patent/EP1345647B1/en
Priority to DE60139637T priority patent/DE60139637D1/en
Publication of US6387073B1 publication Critical patent/US6387073B1/en
Application granted granted Critical
Publication of US20020066748A1 publication Critical patent/US20020066748A1/en
Assigned to MORGAN STANLEY SENIOR FUNDING, INC. reassignment MORGAN STANLEY SENIOR FUNDING, INC. SECURITY AGREEMENT Assignors: CARDINAL HEALTH 400, INC., CARDINAL HEALTH 406, LLC, CARDINAL HEALTH 409, INC., CARDINAL HEALTH 421, INC., CARDINAL HEALTH PTS, LLC, GLACIER CORPORATION, PTS ACQUISITION CORP., PTS INTERMEDIATE HOLDINGS LLC, R.P. SCHERER TECHNOLOGIES, INC.
Assigned to CATALENT USA WOODSTOCK, INC., CATALENT USA PACKAGING, LLC, CATALENT PHARMA SOLUTIONS, LLC, CATALENT USA PAINTBALL, INC., CATALENT PHARMA SOLUTIONS, INC. reassignment CATALENT USA WOODSTOCK, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: CARDINAL HEALTH 400, INC., CARDINAL HEALTH 406, LLC, CARDINAL HEALTH 409, INC., CARDINAL HEALTH 421, INC., CARDINAL HEALTH PTS, LLC
Anticipated expiration legal-status Critical
Assigned to CATALENT PHARMA SOLUTIONS, LLC, CATALENT USA WOODSTOCK, INC. (FORMERLY KNOWN AS CARDINAL HEALTH 400, INC.), R.P. SCHERER TECHNOLOGIES, LLC (F/K/A R.P. SCHERER TECHNOLOGIES, INC.) reassignment CATALENT PHARMA SOLUTIONS, LLC PARTIAL RELEASE OF SECURITY INTEREST Assignors: JPMORGAN CHASE BANK, N.A.
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093Containers having several compartments for products to be mixed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/0015Devices specially adapted for taking medicines
    • A61J7/0046Cups, bottles or bags
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D1/00Containers having bodies formed in one piece, e.g. by casting metallic material, by moulding plastics, by blowing vitreous material, by throwing ceramic material, by moulding pulped fibrous material, by deep-drawing operations performed on sheet material
    • B65D1/02Bottles or similar containers with necks or like restricted apertures, designed for pouring contents
    • B65D1/0223Bottles or similar containers with necks or like restricted apertures, designed for pouring contents characterised by shape
    • B65D1/023Neck construction
    • B65D1/0238Integral frangible closures
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D51/00Closures not otherwise provided for
    • B65D51/24Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes
    • B65D51/28Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials
    • B65D51/2807Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials the closure presenting means for placing the additional articles or materials in contact with the main contents by acting on a part of the closure without removing the closure, e.g. by pushing down, pulling up, rotating or turning a part of the closure, or upon initial opening of the container
    • B65D51/2814Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials the closure presenting means for placing the additional articles or materials in contact with the main contents by acting on a part of the closure without removing the closure, e.g. by pushing down, pulling up, rotating or turning a part of the closure, or upon initial opening of the container the additional article or materials being released by piercing, cutting or tearing an element enclosing it
    • B65D51/2828Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials the closure presenting means for placing the additional articles or materials in contact with the main contents by acting on a part of the closure without removing the closure, e.g. by pushing down, pulling up, rotating or turning a part of the closure, or upon initial opening of the container the additional article or materials being released by piercing, cutting or tearing an element enclosing it said element being a film or a foil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06Ampoules or carpules
    • A61J1/067Flexible ampoules, the contents of which are expelled by squeezing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202Separating means
    • A61J1/2027Separating means having frangible parts

Definitions

  • This invention relates to a hermetically sealed container which includes a body filled with a liquid and, more particularly, to an insert for such a container adapted to store and thereafter dispense a medicament such as a tablet into the liquid in the container.
  • Hermetically sealed containers can be readily produced by the so-called blow/fill/seal techniques. Utilizing such techniques, a container body is first blow molded from an extruded parison segment, then charged (or filled) with a desired liquid, and thereafter sealed with a preformed closure insert. See, for example, the container structure disclosed in U.S. Pat. No. 4,596,110 to Weiler.
  • the liquid in the container body is typically dispensed through the insert and then mixed with another liquid or solid deposit prior to being ingested or otherwise used.
  • a disadvantage associated with the mixing of a deposit or the like into the liquid dispensed from the container prior to ingestion or use is the increased risk of contamination inherent in the handling, manipulation and mixing of the deposit such as a tablet or the like in a non-sterile environment.
  • a hermetically sealed container of the present invention incorporates a preformed medicament bearing insert assembly adapted and structured to store and thereafter dispense a solid medicament, such as a medicinal tablet or the like, into a liquid contained in the body of the container.
  • the insert assembly defines a base member with sealed cavity having a rupturable unitary membrane therewith and a solid medicament contained in the cavity.
  • a plunger provided in the insert assembly is adapted to penetrate the membrane so that the medicament can drop into the body of the container when the plunger is activated.
  • the plunger can be axially slidable or threaded, as desired.
  • the membrane is not completely severed from the base member, however, to dispense the medicament.
  • the medicament can be a tablet, a capsule, a pill, an aliquot of a powder, and the like.
  • the insert assembly is encapsulated within a hermetically sealed container molded of a thermoplastic material and having a body portion, a neck portion, and an severable overcap unitary therewith.
  • the neck portion defines a socket for the insert assembly.
  • the severable overcap is delineated from the neck portion by a peripheral frangible web, and protects the insert assembly during storage and handling from premature activation.
  • the plunger which is part of the insert assembly, can be activated to release the medicament into the body of the container by urging the plunger against the membrane so as to partially sever the membrane from the insert assembly.
  • FIG. 1 is a perspective view of a hermetically sealed container embodying the present invention
  • FIG. 2 is an enlarged, partial front elevational view, partially broken away and shows the insert received in a socket provided in the neck portion of the container;
  • FIG. 3 is a cross-sectional view of the container socket and insert
  • FIG. 4 is a cross-sectional view of the container socket and insert structure where the plunger of the insert assembly has pierced the membrane thereof preparatory to medicament release;
  • FIG. 5 is a cross-sectional view of the container socket and insert assembly depicting the plunger in a position where the medicament is released from the insert assembly into the body of the container;
  • FIG. 6 is an enlarged, partial front sectional view of an alternate insert assembly embodying the present invention.
  • FIG. 7 is a view similar to FIG. 6 and showing a medicament being dispensed
  • FIG. 8 is an enlarged, front sectional view of an alternate container embodying the present invention.
  • FIG. 9 is an enlarged partial front elevational view, partially broken away, and showing the dispensing nozzle of the container.
  • FIG. 10 is a perspective view depicting the container of FIG. 1 in its dispensing position with the overcap and dispensing cap removed therefrom and the medicament in the liquid dissolved in the contents of the container.
  • the container of the present invention will be described in a normal (upright) operating position and terms such as upper, lower, horizontal, etc., will be used with reference to this position. It will be understood, however, that the container and the insert assembly of the present invention may be manufactured, stored, transported, used, and sold in an orientation other than the position described.
  • FIG. 1 A formed, filled, and hermetically sealed thermoplastic container 10 embodying the insert assembly structure of the present invention is illustrated in FIG. 1.
  • Container 10 is preferably fabricated, using a method similar to the method disclosed in U.S. Pat. No. 4,596,110 to Weiler, from conventional molding materials such as polyethylene, polypropylene, and the like, compatible with the contemplated container contents.
  • Container 10 is but one example of such a container, inasmuch as a wide variety of container shapes and sizes can be fabricated.
  • Container 10 includes a hollow body portion 12 having a bottom portion 14 and a top portion 16 .
  • the container body portion 12 is filled with a suitable liquid contents or solution 13 .
  • a medicament containing insert assembly 46 is received in a socket 44 provided in a neck portion 38 of the container 10 .
  • a severable overcap 48 envelops the upper part of insert assembly 46 .
  • the bottom portion 14 of the container 10 terminates in a dispensing nozzle 18 which is in fluid flow communication with the container body portion 12 and the liquid contents 13 therein.
  • the container body portion 12 terminates in the neck portion 38 unitary therewith which includes a generally cylindrical throat portion 40 defining a hollow passageway 42 .
  • Socket 44 is defined by throat portion 40 and is unitary therewith. Socket 44 is sized to receive the insert assembly 46 .
  • Severable overcap 48 envelops insert assembly 46 and is delineated from the socket 44 by a frangible web 49 .
  • overcap 48 includes two spaced apart unitary and diametrically opposed grasping wings 50 and 52 to facilitate removal of the overcap 48 when the container 10 is prepared for use.
  • Insert assembly 46 is a separately fabricated assembly adapted to be inserted, immobilized and subsequently sealed within the socket 44 of the container 10 using a top insertion method disclosed in, for example, U.S. Pat. No. 4,596,110 to Weiler and U.S. Pat. No. 4,707,966 to Weiler et al.
  • the insert assembly 46 may be made of the same type of material as the container 10 , i.e., polyethylene or polypropylene, but can also be molded from a different material such as acrylonitrile-butadiene-styrene (ABS), and the like.
  • the insert assembly 46 includes a base member 54 which is immobilized and sealed in the socket 44 of the container 10 .
  • the base member 54 defines a medicament pocket 70 and includes first and second collars 56 and 58 , first and second shoulders 60 and 62 and a hollow neck 64 .
  • the shoulder 60 extends between the collars 56 and 58 while the shoulder 62 extends between the collar 58 and the neck 64 .
  • the base member 54 includes an outer surface 66 and defines a generally cylindrical inner passageway 68 which extends through the collars 56 and 58 and the neck 64 and defines the pocket 70 which terminates in a proximal generally circular aperture 72 occluded by a rupturable membrane 76 .
  • Interior face 77 of rupturable membrane 76 seals the interior of the pocket 70 from the container 10 .
  • the rupturable membrane 76 is unitary with and is made of the same material as the base member 54 .
  • the thickness of the material forming the membrane 76 is selected to provide both good sealing and piercing characteristics.
  • Medicament 78 is stored in the pocket 70 and is sealed from the container body 12 by the membrane 76 .
  • Medicament 78 can be, for example, a capsule, a tablet, a pill, or an aliquot of powder, as desired.
  • the neck 64 of the base member 54 additionally includes a distal flange 80 extending radially outwardly from the outer surface 66 adjacent the distal opening 74 .
  • the neck 64 also includes first and second annular ribs 82 and 84 extending outwardly from, and circumferentially around, the outer surface 66 .
  • the rib 82 is positioned parallel to, and spaced from, the flange 80 so as to define a groove 86 therebetween.
  • the rib 84 is positioned parallel to, and spaced from, the shoulder 62 so as to define a groove or pocket 88 therebetween.
  • the insert assembly 46 also includes a plunger 90 movably received in passageway 68 defined in base member 54 .
  • Plunger 90 includes a generally cylindrically shaped head unitary with body portion 93 which extends into the passageway 68 of the member 54 .
  • the proximal end 94 of plunger 90 has a distal radial end face 96 and an outer surface 98 which abuts and slides against the inner surface of the base member 54 that defines the passageway 68 .
  • the solid medicament 78 is stored in the pocket 70 so that it is retained between the end face 96 of the plunger 90 and the membrane 76 .
  • the radial end face 96 also can include a pair of spaced-apart prongs 86 and 88 extending outwardly therefrom which define a cradle for the medicament 78 .
  • An elongate piercing blade 104 extends from the radial end face 96 outwardly toward the membrane 76 . Outer face 106 of blade 104 slides along passageway 68 of the base member 54 .
  • the blade 104 terminates in a pointed tip 108 which is adapted to pierce and partially sever the membrane 76 when the plunger 90 is urged against the membrane 76 .
  • Cap 109 of plunger 90 is unitary with the proximal end 94 of plunger body portion 93 and comprises an annular flange 110 which extends radially outwardly from the outer surface 98 of the plunger body portion 93 adjacent the proximal end 94 thereof.
  • a circumferential wall 112 depends generally downwardly from the flange 110 .
  • the wall 112 is spaced from and generally parallel to the outer surface 98 of the plunger body portion 93 and defines a circumferential hollow sleeve 114 between the wall 112 and the outer surface 98 .
  • Annular flange 110 provides a stop as the plunger 90 is urged against the membrane 76 .
  • the membrane 76 is not fully severed from the base member 54 when medicament 78 is dispensed so as to keep the membrane 76 from dropping into the container 10 along with the medicament 78 .
  • the wall 112 includes an inner surface 116 and a peripheral distal end 118 .
  • a finger 120 extends circumferentially and radially inwardly from the inner surface 116 adjacent the peripheral distal end 118 thereof and abuts retaining rib 82 .
  • the nozzle 18 at the bottom of container 10 is hollow, generally frustoconical in shape, and at distal end 20 defines an axial dispensing aperture 22 .
  • a unitary but removable dispensing cap member 26 is attached to the bottom distal end 20 of the nozzle 18 .
  • Dispensing member 26 includes a generally cylindrically shaped twist-off cap 27 including a circumferential lip or edge 28 which is unitary with the lip 24 of the nozzle 18 .
  • the lip 24 is delineated from the lip 28 by a circumferential frangible web 30 unitary therewith.
  • Dispensing member 26 additionally includes a flat lower base 32 which is unitary with the cap 27 and wings 34 and 36 extending upwardly from opposite ends of the base 32 and on opposite sides of the nozzle 18 in a diametrically opposed relationship.
  • the overcap 48 is severed and removed from the container 10 to obtain access to the insert assembly 46 and the plunger 90 thereof. This is achieved by grasping the wings 50 and 52 of the overcap 48 and then exerting a substantially simultaneous twisting and lifting motion to the overcap 48 so as to break the unitary frangible web 49 (FIG. 2) between overcap 48 and container top portion 16 .
  • FIG. 3 shows the container 10 with the overcap 48 removed therefrom.
  • the plunger 90 of the insert assembly 46 is in its normal upright locked position where the finger 120 on the cap 109 of the plunger 90 is lodged in the pocket 86 defined on the neck 64 of the member 54 between flange 80 and retaining rib 82 .
  • FIG. 4 depicts the top of the container 10 and the insert assembly 46 after the plunger 90 has been partially depressed downwardly in the direction of the base member 54 .
  • the finger 120 has been dislodged from the pocket 86 and has passed over the rib 82 on the neck 64 into a position where the finger 120 is located between the ribs 82 and 84 on the neck 64 .
  • the depression of the plunger 90 also causes the downward movement of the elongate blade 104 extending outwardly from the end of the head 92 which, in turn, causes the tip 108 thereof to contact and pierce the membrane 76 .
  • the container 10 at this point can be shaken to allow the composition of the medicament 78 to be thoroughly distributed in the liquid 13 .
  • the container 10 then can be turned upside down into a position where the dispensing nozzle 18 faces up and the dispensing member 26 is severed and removed from the nozzle 18 by grasping the wings 34 and 36 thereof and then exerting a simultaneous twisting and lifting motion to break the frangible web 30 .
  • the container 10 is then returned to the dispensing position of FIG. 7 for dispensing the liquid mixture.
  • FIGS. 6 and 7 depict an alternate insert assembly, generally designated 246 , which includes a plunger 290 with a plunger body portion 293 provided with external threads 295 that engage mating internal threads 297 formed in the base member 254 along the inner surface which defines a central passageway 268 thereof.
  • the plunger body portion 293 is urged against the membrane 276 by turning rather than pushing to partially sever the membrane 276 from base member 254 .
  • the insert assembly 246 also differs in structure from the insert assembly 46 in that the outer surface 298 of plunger body portion 293 includes a knurled flange portion 299 which extends radially outwardly therefrom adjacent the proximal end 294 and allows the plunger body portion 293 to be easily grasped and turned.
  • a second flange portion 301 extends radially outwardly from the outer surface 298 in a parallel and spaced relationship relative to the knurled flange portion 299 .
  • the flange portion 301 defines a radial shoulder 303 which, as shown in FIG. 7, is adapted to abut against the shoulder 262 defined at the proximal end 263 of the base member 254 to limit the depth to which the plunger body portion 293 can be threaded into the passageway 268 defined in the base member 254 .
  • the membrane 276 differs in structure from the membrane 176 associated with the insert assembly 46 in that the membrane 276 includes a peripheral portion 277 which is thinner than a central portion 279 thereof to further enhance the piercing of the membrane 276 by the tip or edge 208 of the piercing blade 204 which extends downwardly from the distal end face 296 of the plunger body portion 293 .
  • the plunger 290 of the insert assembly 246 additionally differs in structure from the plunger 90 of the insert assembly 46 in that the plunger 290 includes an interior cavity 305 which terminates in an opening 307 in the distal end face 296 thereof.
  • the opening 307 defines a cradle for the medicament tablet 278 housed in the pocket 270 in a manner similar to the cradle defined by the prongs 86 and 88 of the base member 54 of the insert assembly 46 .
  • FIG. 8 depicts yet a further alternate container embodiment 310 including an insert assembly 346 which is similar in structure and function to the insert assembly 246 shown in FIGS. 6 and 7.
  • the container embodiment 310 further includes a severable overcap 348 with grasping wings 350 and 351 unitary therewith.
  • Overcap 348 is similar in structure to the overcap 48 shown in FIGS. 1 and 2, except that the thermoplastic material forming the overcap 348 also defines a container top portion 422 and stays together with body portion 393 of plunger 390 as body portion 393 is turned. In this particular embodiment, overcap 348 need not be removed in order to activate plunger 390 .
  • Flange portions 399 and 401 receive therebetween inwardly extending flange or ring 425 of the material that forms overcap 348 .
  • thermoplastic material forming the overcap 348 is brought into intimate and abutting relationship with the outer surface of the plunger 390 and the groove 426 defined therein by flange portions 399 and 401 during the molding of the container 310 and, more particularly, after the insertion and sealing of the insert assembly 346 as is known in the art and shown in U.S. Pat. No. 4,596,110 to Weiler and U.S. Pat. No. 4,707,966 to Weiler et al.
  • the overcap 348 is permanently secured to the plunger 390 such that, when the overcap 348 is twisted to break the unitary frangible web 349 , the plunger 390 turns with the overcap 348 .
  • the subsequent turning of the overcap 348 causes the downwardly movement of the plunger 390 into piercing and severing contact with the membrane 376 in the same manner as described above with respect to the plunger embodiment 290 to dispense medicament 378 .
  • containers including alternate insert assemblies which house and subsequently dispense a medicament into the container body thus eliminating the risk of contamination which can result when medicaments are handled or exposed to non-sterile environments prior to being mixed with a carrier liquid.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mechanical Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ceramic Engineering (AREA)
  • Closures For Containers (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

A hermetically sealed container and a medicament bearing insert assembly therefor are disclosed. The medicament bearing insert assembly is protected by a severable overcap. A pocket within the insert assembly is provided with a pierceable membrane. Rupture of the membrane by a built-in plunger causes the medicament to drop out of the pocket and into the container where it is mixed with the container contents.

Description

    FIELD OF THE INVENTION
  • This invention relates to a hermetically sealed container which includes a body filled with a liquid and, more particularly, to an insert for such a container adapted to store and thereafter dispense a medicament such as a tablet into the liquid in the container. [0001]
  • BACKGROUND OF THE INVENTION
  • Hermetically sealed containers can be readily produced by the so-called blow/fill/seal techniques. Utilizing such techniques, a container body is first blow molded from an extruded parison segment, then charged (or filled) with a desired liquid, and thereafter sealed with a preformed closure insert. See, for example, the container structure disclosed in U.S. Pat. No. 4,596,110 to Weiler. [0002]
  • The liquid in the container body is typically dispensed through the insert and then mixed with another liquid or solid deposit prior to being ingested or otherwise used. A disadvantage associated with the mixing of a deposit or the like into the liquid dispensed from the container prior to ingestion or use is the increased risk of contamination inherent in the handling, manipulation and mixing of the deposit such as a tablet or the like in a non-sterile environment. [0003]
  • There is thus presently a need for a hermetically sealed container where the liquid or solid deposit intended to be mixed with the liquid in the container is stored in the container and mixed with the liquid in the container prior to being dispensed from the container to eliminate the risk of contamination and to simplify the mixing and dispensing procedure. [0004]
  • SUMMARY OF THE INVENTION
  • A hermetically sealed container of the present invention incorporates a preformed medicament bearing insert assembly adapted and structured to store and thereafter dispense a solid medicament, such as a medicinal tablet or the like, into a liquid contained in the body of the container. [0005]
  • More particularly, the insert assembly defines a base member with sealed cavity having a rupturable unitary membrane therewith and a solid medicament contained in the cavity. A plunger provided in the insert assembly is adapted to penetrate the membrane so that the medicament can drop into the body of the container when the plunger is activated. The plunger can be axially slidable or threaded, as desired. The membrane is not completely severed from the base member, however, to dispense the medicament. [0006]
  • The medicament can be a tablet, a capsule, a pill, an aliquot of a powder, and the like. [0007]
  • The insert assembly is encapsulated within a hermetically sealed container molded of a thermoplastic material and having a body portion, a neck portion, and an severable overcap unitary therewith. The neck portion defines a socket for the insert assembly. The severable overcap is delineated from the neck portion by a peripheral frangible web, and protects the insert assembly during storage and handling from premature activation. When the overcap is removed or severed from the container by a twisting action, the plunger, which is part of the insert assembly, can be activated to release the medicament into the body of the container by urging the plunger against the membrane so as to partially sever the membrane from the insert assembly. [0008]
  • Other advantages and features of the present invention will be more readily apparent from the following detailed description of the preferred embodiment of the invention, the accompanying drawings, and the appended claims.[0009]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • In the Drawings, [0010]
  • FIG. 1 is a perspective view of a hermetically sealed container embodying the present invention; [0011]
  • FIG. 2 is an enlarged, partial front elevational view, partially broken away and shows the insert received in a socket provided in the neck portion of the container; [0012]
  • FIG. 3 is a cross-sectional view of the container socket and insert; [0013]
  • FIG. 4 is a cross-sectional view of the container socket and insert structure where the plunger of the insert assembly has pierced the membrane thereof preparatory to medicament release; [0014]
  • FIG. 5 is a cross-sectional view of the container socket and insert assembly depicting the plunger in a position where the medicament is released from the insert assembly into the body of the container; [0015]
  • FIG. 6 is an enlarged, partial front sectional view of an alternate insert assembly embodying the present invention; [0016]
  • FIG. 7 is a view similar to FIG. 6 and showing a medicament being dispensed; [0017]
  • FIG. 8 is an enlarged, front sectional view of an alternate container embodying the present invention; [0018]
  • FIG. 9 is an enlarged partial front elevational view, partially broken away, and showing the dispensing nozzle of the container; and [0019]
  • FIG. 10 is a perspective view depicting the container of FIG. 1 in its dispensing position with the overcap and dispensing cap removed therefrom and the medicament in the liquid dissolved in the contents of the container.[0020]
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • The invention disclosed herein is, of course, susceptible of embodiment in many different forms. Shown in the drawings and described below in detail are preferred embodiments of the container of the present invention. It is to be understood, however, that the present disclosure is an exemplification of the principles of the invention and does not limit the invention to the illustrated embodiments. [0021]
  • For ease of description, the container of the present invention will be described in a normal (upright) operating position and terms such as upper, lower, horizontal, etc., will be used with reference to this position. It will be understood, however, that the container and the insert assembly of the present invention may be manufactured, stored, transported, used, and sold in an orientation other than the position described. [0022]
  • A formed, filled, and hermetically sealed [0023] thermoplastic container 10 embodying the insert assembly structure of the present invention is illustrated in FIG. 1. Container 10 is preferably fabricated, using a method similar to the method disclosed in U.S. Pat. No. 4,596,110 to Weiler, from conventional molding materials such as polyethylene, polypropylene, and the like, compatible with the contemplated container contents.
  • [0024] Container 10 is but one example of such a container, inasmuch as a wide variety of container shapes and sizes can be fabricated. Container 10 includes a hollow body portion 12 having a bottom portion 14 and a top portion 16. The container body portion 12 is filled with a suitable liquid contents or solution 13. A medicament containing insert assembly 46 is received in a socket 44 provided in a neck portion 38 of the container 10. A severable overcap 48 envelops the upper part of insert assembly 46. The bottom portion 14 of the container 10 terminates in a dispensing nozzle 18 which is in fluid flow communication with the container body portion 12 and the liquid contents 13 therein.
  • As shown in FIGS. 1, 2 and [0025] 3, at the top portion 16, the container body portion 12 terminates in the neck portion 38 unitary therewith which includes a generally cylindrical throat portion 40 defining a hollow passageway 42. Socket 44 is defined by throat portion 40 and is unitary therewith. Socket 44 is sized to receive the insert assembly 46. Severable overcap 48 envelops insert assembly 46 and is delineated from the socket 44 by a frangible web 49. Preferably, overcap 48 includes two spaced apart unitary and diametrically opposed grasping wings 50 and 52 to facilitate removal of the overcap 48 when the container 10 is prepared for use.
  • [0026] Insert assembly 46 is a separately fabricated assembly adapted to be inserted, immobilized and subsequently sealed within the socket 44 of the container 10 using a top insertion method disclosed in, for example, U.S. Pat. No. 4,596,110 to Weiler and U.S. Pat. No. 4,707,966 to Weiler et al. The insert assembly 46 may be made of the same type of material as the container 10, i.e., polyethylene or polypropylene, but can also be molded from a different material such as acrylonitrile-butadiene-styrene (ABS), and the like.
  • Referring to FIGS. 2 and 3, the [0027] insert assembly 46 includes a base member 54 which is immobilized and sealed in the socket 44 of the container 10. The base member 54 defines a medicament pocket 70 and includes first and second collars 56 and 58, first and second shoulders 60 and 62 and a hollow neck 64. The shoulder 60 extends between the collars 56 and 58 while the shoulder 62 extends between the collar 58 and the neck 64. The base member 54 includes an outer surface 66 and defines a generally cylindrical inner passageway 68 which extends through the collars 56 and 58 and the neck 64 and defines the pocket 70 which terminates in a proximal generally circular aperture 72 occluded by a rupturable membrane 76.
  • [0028] Interior face 77 of rupturable membrane 76 seals the interior of the pocket 70 from the container 10. The rupturable membrane 76 is unitary with and is made of the same material as the base member 54. The thickness of the material forming the membrane 76 is selected to provide both good sealing and piercing characteristics.
  • [0029] Medicament 78 is stored in the pocket 70 and is sealed from the container body 12 by the membrane 76. Medicament 78 can be, for example, a capsule, a tablet, a pill, or an aliquot of powder, as desired.
  • The [0030] neck 64 of the base member 54 additionally includes a distal flange 80 extending radially outwardly from the outer surface 66 adjacent the distal opening 74. The neck 64 also includes first and second annular ribs 82 and 84 extending outwardly from, and circumferentially around, the outer surface 66. The rib 82 is positioned parallel to, and spaced from, the flange 80 so as to define a groove 86 therebetween. The rib 84 is positioned parallel to, and spaced from, the shoulder 62 so as to define a groove or pocket 88 therebetween.
  • The [0031] insert assembly 46 also includes a plunger 90 movably received in passageway 68 defined in base member 54. Plunger 90 includes a generally cylindrically shaped head unitary with body portion 93 which extends into the passageway 68 of the member 54. The proximal end 94 of plunger 90 has a distal radial end face 96 and an outer surface 98 which abuts and slides against the inner surface of the base member 54 that defines the passageway 68.
  • The [0032] solid medicament 78 is stored in the pocket 70 so that it is retained between the end face 96 of the plunger 90 and the membrane 76. The radial end face 96 also can include a pair of spaced-apart prongs 86 and 88 extending outwardly therefrom which define a cradle for the medicament 78. An elongate piercing blade 104 extends from the radial end face 96 outwardly toward the membrane 76. Outer face 106 of blade 104 slides along passageway 68 of the base member 54. The blade 104 terminates in a pointed tip 108 which is adapted to pierce and partially sever the membrane 76 when the plunger 90 is urged against the membrane 76.
  • [0033] Cap 109 of plunger 90 is unitary with the proximal end 94 of plunger body portion 93 and comprises an annular flange 110 which extends radially outwardly from the outer surface 98 of the plunger body portion 93 adjacent the proximal end 94 thereof. A circumferential wall 112 depends generally downwardly from the flange 110. The wall 112 is spaced from and generally parallel to the outer surface 98 of the plunger body portion 93 and defines a circumferential hollow sleeve 114 between the wall 112 and the outer surface 98. Annular flange 110 provides a stop as the plunger 90 is urged against the membrane 76. The membrane 76 is not fully severed from the base member 54 when medicament 78 is dispensed so as to keep the membrane 76 from dropping into the container 10 along with the medicament 78.
  • The [0034] wall 112 includes an inner surface 116 and a peripheral distal end 118. A finger 120 extends circumferentially and radially inwardly from the inner surface 116 adjacent the peripheral distal end 118 thereof and abuts retaining rib 82.
  • As shown in FIGS. 1, 9 and [0035] 10, the nozzle 18 at the bottom of container 10 is hollow, generally frustoconical in shape, and at distal end 20 defines an axial dispensing aperture 22. A unitary but removable dispensing cap member 26 is attached to the bottom distal end 20 of the nozzle 18. Dispensing member 26 includes a generally cylindrically shaped twist-off cap 27 including a circumferential lip or edge 28 which is unitary with the lip 24 of the nozzle 18. The lip 24 is delineated from the lip 28 by a circumferential frangible web 30 unitary therewith.
  • Dispensing [0036] member 26 additionally includes a flat lower base 32 which is unitary with the cap 27 and wings 34 and 36 extending upwardly from opposite ends of the base 32 and on opposite sides of the nozzle 18 in a diametrically opposed relationship.
  • The use and operation of the [0037] container 10 and the insert assembly 46 thereof for storing, dispensing and thereafter mixing the medication 78 with a liquid 13 in the container body 12 will now be described with reference to FIGS. 2-5, 9 and 10.
  • Initially, the [0038] overcap 48 is severed and removed from the container 10 to obtain access to the insert assembly 46 and the plunger 90 thereof. This is achieved by grasping the wings 50 and 52 of the overcap 48 and then exerting a substantially simultaneous twisting and lifting motion to the overcap 48 so as to break the unitary frangible web 49 (FIG. 2) between overcap 48 and container top portion 16.
  • FIG. 3 shows the [0039] container 10 with the overcap 48 removed therefrom. The plunger 90 of the insert assembly 46 is in its normal upright locked position where the finger 120 on the cap 109 of the plunger 90 is lodged in the pocket 86 defined on the neck 64 of the member 54 between flange 80 and retaining rib 82.
  • FIG. 4 depicts the top of the [0040] container 10 and the insert assembly 46 after the plunger 90 has been partially depressed downwardly in the direction of the base member 54. The finger 120 has been dislodged from the pocket 86 and has passed over the rib 82 on the neck 64 into a position where the finger 120 is located between the ribs 82 and 84 on the neck 64. The depression of the plunger 90 also causes the downward movement of the elongate blade 104 extending outwardly from the end of the head 92 which, in turn, causes the tip 108 thereof to contact and pierce the membrane 76.
  • The continued downward axial movement of the [0041] plunger 90 in the direction of the base member 54 into the position of FIG. 5 where the finger 120 of the plunger 90 is lodged in the pocket 88 on the neck 64 of the base member 54 causes the further downward movement of the plunger body portion 93 through the pocket 70 which, in turn, causes the medicament 78 to be pushed out of the pocket 70 through the now open aperture 72 in the base member 54 and into the container body 12 where the medicament 78 is dissolved and mixed in the liquid 13. The pierced membrane remains with the base member 54, however.
  • The [0042] container 10 at this point can be shaken to allow the composition of the medicament 78 to be thoroughly distributed in the liquid 13. The container 10 then can be turned upside down into a position where the dispensing nozzle 18 faces up and the dispensing member 26 is severed and removed from the nozzle 18 by grasping the wings 34 and 36 thereof and then exerting a simultaneous twisting and lifting motion to break the frangible web 30. The container 10 is then returned to the dispensing position of FIG. 7 for dispensing the liquid mixture.
  • FIGS. 6 and 7 depict an alternate insert assembly, generally designated [0043] 246, which includes a plunger 290 with a plunger body portion 293 provided with external threads 295 that engage mating internal threads 297 formed in the base member 254 along the inner surface which defines a central passageway 268 thereof. In such a case, the plunger body portion 293 is urged against the membrane 276 by turning rather than pushing to partially sever the membrane 276 from base member 254.
  • The [0044] insert assembly 246 also differs in structure from the insert assembly 46 in that the outer surface 298 of plunger body portion 293 includes a knurled flange portion 299 which extends radially outwardly therefrom adjacent the proximal end 294 and allows the plunger body portion 293 to be easily grasped and turned.
  • A [0045] second flange portion 301 extends radially outwardly from the outer surface 298 in a parallel and spaced relationship relative to the knurled flange portion 299. The flange portion 301 defines a radial shoulder 303 which, as shown in FIG. 7, is adapted to abut against the shoulder 262 defined at the proximal end 263 of the base member 254 to limit the depth to which the plunger body portion 293 can be threaded into the passageway 268 defined in the base member 254.
  • The [0046] membrane 276 differs in structure from the membrane 176 associated with the insert assembly 46 in that the membrane 276 includes a peripheral portion 277 which is thinner than a central portion 279 thereof to further enhance the piercing of the membrane 276 by the tip or edge 208 of the piercing blade 204 which extends downwardly from the distal end face 296 of the plunger body portion 293.
  • The [0047] plunger 290 of the insert assembly 246 additionally differs in structure from the plunger 90 of the insert assembly 46 in that the plunger 290 includes an interior cavity 305 which terminates in an opening 307 in the distal end face 296 thereof. The opening 307 defines a cradle for the medicament tablet 278 housed in the pocket 270 in a manner similar to the cradle defined by the prongs 86 and 88 of the base member 54 of the insert assembly 46.
  • The other elements and features of the [0048] alternate insert assembly 246 are similar to the elements and features of the insert assembly 46.
  • FIG. 8 depicts yet a further [0049] alternate container embodiment 310 including an insert assembly 346 which is similar in structure and function to the insert assembly 246 shown in FIGS. 6 and 7. The container embodiment 310 further includes a severable overcap 348 with grasping wings 350 and 351 unitary therewith. Overcap 348 is similar in structure to the overcap 48 shown in FIGS. 1 and 2, except that the thermoplastic material forming the overcap 348 also defines a container top portion 422 and stays together with body portion 393 of plunger 390 as body portion 393 is turned. In this particular embodiment, overcap 348 need not be removed in order to activate plunger 390. Flange portions 399 and 401 receive therebetween inwardly extending flange or ring 425 of the material that forms overcap 348.
  • The thermoplastic material forming the [0050] overcap 348 is brought into intimate and abutting relationship with the outer surface of the plunger 390 and the groove 426 defined therein by flange portions 399 and 401 during the molding of the container 310 and, more particularly, after the insertion and sealing of the insert assembly 346 as is known in the art and shown in U.S. Pat. No. 4,596,110 to Weiler and U.S. Pat. No. 4,707,966 to Weiler et al.
  • As a result, the [0051] overcap 348 is permanently secured to the plunger 390 such that, when the overcap 348 is twisted to break the unitary frangible web 349, the plunger 390 turns with the overcap 348. The subsequent turning of the overcap 348, in turn, causes the downwardly movement of the plunger 390 into piercing and severing contact with the membrane 376 in the same manner as described above with respect to the plunger embodiment 290 to dispense medicament 378.
  • What has thus been disclosed and described are containers including alternate insert assemblies which house and subsequently dispense a medicament into the container body thus eliminating the risk of contamination which can result when medicaments are handled or exposed to non-sterile environments prior to being mixed with a carrier liquid. [0052]

Claims (5)

We claim:
1. A hermetically sealed container which comprises:
a container body portion which terminates into a hollow neck portion that defines a socket;
a medicament bearing insert assembly sealingly received in said socket and including a base member immobilized in said socket and defining a medicament pocket with a proximal aperture occluded by a rupturable membrane unitary with the base member; a solid medicament in said pocket; and a plunger engaged by said base member, movable in said pocket, and adapted to penetrate said membrane so as to dispense the medicament into the container through the proximal aperture in the base member but without fully severing the membrane from the base member; and
a severable overcap unitary with the container and delineated from the neck portion by a frangible web.
2. The container in accordance with claim 1 wherein the plunger is provided with a tip for piercing and rupturing the membrane when the plunger is urged against the membrane.
3. The container in accordance with claim 1 wherein the plunger is slidably movable into said pocket to pierce the membrane.
4. The container in accordance with claim 1 wherein the plunger is threadedly movable into said pocket to sever a portion of the membrane about the periphery thereof.
5. The container in accordance with claim 4 wherein the overcap is permanently secured to said plunger and said plunger is threadingly movable into said pocket in response to the turning of said overcap.
US09/731,128 2000-12-06 2000-12-06 Hermetically sealed container with medicament storing and dispensing insert Expired - Lifetime US6387073B1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US09/731,128 US6387073B1 (en) 2000-12-06 2000-12-06 Hermetically sealed container with medicament storing and dispensing insert
CA002430715A CA2430715C (en) 2000-12-06 2001-12-04 Hermetically sealed container with medicament storing and dispensing insert
AT01989899T ATE439824T1 (en) 2000-12-06 2001-12-04 CONTAINER WITH INSERT FOR STORING AND DISPENSING MEDICATIONS
DE60139637T DE60139637D1 (en) 2000-12-06 2001-12-04 CONTAINER WITH INPUT FOR STORING AND DISTRIBUTING MEDICAMENTS
MXPA03005089A MXPA03005089A (en) 2000-12-06 2001-12-04 Container with medicamentstoring and dispensing insert.
PCT/US2001/046384 WO2002045789A1 (en) 2000-12-06 2001-12-04 Container with medicamentstoring and dispensing insert
JP2002547569A JP2004515279A (en) 2000-12-06 2001-12-04 Closed container with insert for storing and delivering medication
EP01989899A EP1345647B1 (en) 2000-12-06 2001-12-04 Container with medicament storing and dispensing insert

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/731,128 US6387073B1 (en) 2000-12-06 2000-12-06 Hermetically sealed container with medicament storing and dispensing insert

Publications (2)

Publication Number Publication Date
US6387073B1 US6387073B1 (en) 2002-05-14
US20020066748A1 true US20020066748A1 (en) 2002-06-06

Family

ID=24938182

Family Applications (1)

Application Number Title Priority Date Filing Date
US09/731,128 Expired - Lifetime US6387073B1 (en) 2000-12-06 2000-12-06 Hermetically sealed container with medicament storing and dispensing insert

Country Status (8)

Country Link
US (1) US6387073B1 (en)
EP (1) EP1345647B1 (en)
JP (1) JP2004515279A (en)
AT (1) ATE439824T1 (en)
CA (1) CA2430715C (en)
DE (1) DE60139637D1 (en)
MX (1) MXPA03005089A (en)
WO (1) WO2002045789A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060057257A1 (en) * 2003-10-27 2006-03-16 Ma Mike X Twist-open closure having inclined frangible membrane
US20060108314A1 (en) * 2004-11-23 2006-05-25 Cho Young K Sanitary double cap allowing addition of adjunct to contents of a container
US20070262045A1 (en) * 2004-11-08 2007-11-15 Bernd Hansen Container, in Particular an Ampoule
US20110000800A1 (en) * 2009-02-11 2011-01-06 Robert Dale Rohr Inverted dome to supply dose
US20110054437A1 (en) * 2008-04-17 2011-03-03 Philippe Perovitch Device for conserving, extemporaneously preparing, and administering an active principle
WO2012052853A3 (en) * 2010-10-21 2012-11-01 Aptalis Pharma Limited Oral dosing device for administration of medication
KR101403015B1 (en) 2012-02-29 2014-06-03 주식회사태준제약 Dispensing container
US10293993B2 (en) 2009-11-05 2019-05-21 Liquid Health Labs, Inc. Universal domed closure to supply dose

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10007581C2 (en) * 2000-02-21 2003-05-28 3M Espe Ag Mixing capsule, process for its production and its use
US20050019272A1 (en) * 2003-07-24 2005-01-27 Harrison Johnnie Mae Portable mouth wash system
KR100593245B1 (en) * 2003-12-30 2006-06-28 조영국 bottle cap assembly for simultaneously dissolve additives
US20050167297A1 (en) * 2004-01-30 2005-08-04 Emanuel Shenkar Easy-open closure for container and method of use
US20050167296A1 (en) * 2004-01-30 2005-08-04 Emanuel Shenkar Dosing closure and method of using
US20050167295A1 (en) * 2004-01-30 2005-08-04 Emanuel Shenkar Portion closure and method of using
US8215481B1 (en) * 2004-02-18 2012-07-10 Knickerbocker Michael G Container closure for retaining an additive material
JP5127456B2 (en) * 2004-11-04 2013-01-23 ヴィズ エンタープライゼズ,エルエルシー Multi-chamber container and its lid
US20080156674A1 (en) * 2006-11-09 2008-07-03 Puricore, Inc. Apparatuses and systems for storing, dispensing, and reconstituting materials
US8276748B2 (en) * 2007-03-16 2012-10-02 The Coca-Cola Company Ingredient release spout
US8443969B2 (en) * 2007-03-16 2013-05-21 The Coca-Cola Company Ingredient release spout
US9592940B2 (en) * 2007-03-16 2017-03-14 The Coca-Cola Company Ingredient release spout
PE20090099A1 (en) * 2007-03-30 2009-02-13 Schering Corp MULTIPLE COMPARTMENT PACKAGING
FR2922867B1 (en) * 2007-10-31 2009-12-25 Idecap DOSING DEVICE ADAPTABLE ON A CONTAINER
US7874420B2 (en) 2009-02-09 2011-01-25 Darren Coon Affixable dispensing capsule
US9067716B2 (en) 2011-09-30 2015-06-30 Federico Intriago Cap assembly for dispensing a dispensable component and method of making and using the same
EP3077031B1 (en) * 2013-12-04 2020-11-25 Hollister Incorporated Urinary catheter protective tips having a fluid reservoir
GB201415869D0 (en) * 2014-09-08 2014-10-22 Eulysis Uk Ltd Container And Closure
ITUA20162141A1 (en) * 2016-03-31 2017-10-01 Bormioli Pharma Spa CLOSING CAPS
US11834239B2 (en) * 2021-03-04 2023-12-05 Psimos, Inc. Reusable dispenser lid

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2773591A (en) 1952-10-22 1956-12-11 Novo Terapeutisk Labor As Vessel with sterile closure for separate storage of at least two substances
US2721552A (en) 1954-03-29 1955-10-25 Nosik William Andre Multiple chamber container
FR1528920A (en) * 1967-05-05 1968-06-14 Multi-capacity cartridge for conditioning pre-dosed substances
AT318132B (en) 1969-08-01 1974-09-25 Dentaire Ivoclar Ets Mixing container for holding substances that react with one another for the production of ready-to-use paste-like dental preparations
DE1939315B2 (en) 1969-08-01 1973-03-15 Etablissement Dentaire Ivoclar, Schaan (Liechtenstein) MULTI-CHAMBER CONTAINER FOR THE ACCOMMODATION OF REACTIVE SUBSTANCES FOR THE PRODUCTION OF READY-TO-USE DENTAL PREPARATIONS
BE759385A (en) * 1970-01-17 1971-04-30 Vetreria F Lli Benecchi Di Ben MEDICINAL BOTTLE PROVIDED WITH A METAL RETAINING CAPSULE TEARABLE AND A CAP WITH BOTTOM TEARABLE BY A BREAKING SLEEVE
US3762542A (en) 1971-11-24 1973-10-02 Questor Corp Infant feeding means
US3924741A (en) * 1975-03-04 1975-12-09 Gibson Ass Inc Two-compartment container
FR2342914A1 (en) 1976-03-02 1977-09-30 Oreal PACKAGING DEVICE FOR TWO INSULATED PRODUCTS ONE OF THE OTHER BEFORE DISTRIBUTION
IL52695A (en) 1977-08-10 1979-11-30 Silmet Ltd Mixing capsule
US4707966A (en) 1981-08-26 1987-11-24 Automatic Liquid Packaging, Inc. Container with an encapsulated top insert and method and apparatus for making same
US4596110A (en) 1981-08-26 1986-06-24 Automatic Liquid Packaging, Inc. Container with insert having a fully or partially encapsulating seal with a frangible web formed against said insert
FR2564433B1 (en) 1984-05-15 1986-10-03 Oreal CONTAINER FOR PACKAGING AND DISPENSING A LIQUID PRODUCT AND AT LEAST ONE SEPARATE ADDITIONAL PRODUCT DURING STORAGE
IT1185850B (en) * 1985-08-02 1987-11-18 Zambon Spa DROP TANK CAP FOR BOTTLES
US4903865A (en) 1988-09-19 1990-02-27 Janowitz C Michael Push button cap containing an additive for containers
JP3146465B2 (en) 1992-03-13 2001-03-19 株式会社ニッショー Chemical injection device
US5649637A (en) * 1994-06-02 1997-07-22 Automatic Liquid Packaging, Inc. Torque-resistant closure for a hermetically sealed container
FR2722765B1 (en) * 1994-07-25 1996-08-23 Oreal CONTAINER ALLOWING THE STORAGE OF AT LEAST TWO PRODUCTS, THE MIXTURE OF THESE PRODUCTS AND THE DISTRIBUTION OF THE MIXTURE THUS OBTAINED
DE69602949T2 (en) * 1995-07-29 2000-02-17 Rocep-Lusol Holdings Ltd., Renfrew METHOD FOR MIXING A FLUID WITH A LIQUID
US5711420A (en) 1996-02-20 1998-01-27 Canning Concepts, Inc. Apparatus for dispensing a substance in a liquid beverage
US5772017A (en) 1996-10-25 1998-06-30 Kang; Heung Sun Beverage mixing dispenser device
IT1292677B1 (en) * 1997-02-28 1999-02-11 Bormioli Metalplast Spa PACKAGING TO KEEP THE PRODUCTS SEPARATE BEFORE USE.
ES2221159T3 (en) * 1997-03-12 2004-12-16 Fredrick Coory DOWNLOAD CAPERUTA WITH DISPOSABLE BASKET CONTAINING TABLETS.
FR2765861B1 (en) * 1997-07-08 1999-09-24 Oreal DEVICE FOR THE SEPARATE PACKAGING OF TWO COMPONENTS AND MANUFACTURING PROCESS
US5927549A (en) * 1998-03-20 1999-07-27 Aptargroup, Inc. Dispensing structure with frangible membrane for separating two products
DE19812657A1 (en) * 1998-03-23 1998-12-24 Wella Ag Two-component container for the temporary storage of peroxide and hair dye
US5950819A (en) 1998-05-08 1999-09-14 Sellars; Andy Storage, admixing, and dispensing system
US6003728A (en) * 1998-10-22 1999-12-21 Aptargroup, Inc. Dispensing structure with an openable member for separating two products
US6152296A (en) * 1998-11-06 2000-11-28 Shih; Kuang-Sheng Additive holder for a pet bottle
FR2789372B1 (en) * 1999-02-10 2001-04-13 Oreal DEVICE FOR STORING THREE COMPONENTS, THEIR MIXTURE AND THE DISPENSING OF THE MIXTURE THUS OBTAINED
AU6066799A (en) * 1999-11-26 2001-05-31 Lily Hsu Container device for separately enclosing two different substances

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060057257A1 (en) * 2003-10-27 2006-03-16 Ma Mike X Twist-open closure having inclined frangible membrane
US7337921B2 (en) 2003-10-27 2008-03-04 Portola Packaging, Inc. Twist-open closure having inclined frangible membrane
US20070262045A1 (en) * 2004-11-08 2007-11-15 Bernd Hansen Container, in Particular an Ampoule
US8087524B2 (en) * 2004-11-08 2012-01-03 Bernd Hansen Container, in particular an ampoule
US20060108314A1 (en) * 2004-11-23 2006-05-25 Cho Young K Sanitary double cap allowing addition of adjunct to contents of a container
US7748550B2 (en) * 2004-11-23 2010-07-06 Young Kook Cho Sanitary double cap allowing addition of adjunct to contents of a container
US20110054437A1 (en) * 2008-04-17 2011-03-03 Philippe Perovitch Device for conserving, extemporaneously preparing, and administering an active principle
US8870844B2 (en) * 2008-04-17 2014-10-28 Philippe Perovitch Device for conserving, extemporaneously preparing, and administering an active principle
US20110000800A1 (en) * 2009-02-11 2011-01-06 Robert Dale Rohr Inverted dome to supply dose
US8490786B2 (en) * 2009-02-11 2013-07-23 Liquid Health Labs, Inc. Inverted dome to supply dose
US10293993B2 (en) 2009-11-05 2019-05-21 Liquid Health Labs, Inc. Universal domed closure to supply dose
WO2012052853A3 (en) * 2010-10-21 2012-11-01 Aptalis Pharma Limited Oral dosing device for administration of medication
KR101403015B1 (en) 2012-02-29 2014-06-03 주식회사태준제약 Dispensing container

Also Published As

Publication number Publication date
MXPA03005089A (en) 2004-10-15
JP2004515279A (en) 2004-05-27
CA2430715A1 (en) 2002-06-13
EP1345647B1 (en) 2009-08-19
ATE439824T1 (en) 2009-09-15
CA2430715C (en) 2010-03-09
WO2002045789A1 (en) 2002-06-13
DE60139637D1 (en) 2009-10-01
US6387073B1 (en) 2002-05-14
EP1345647A1 (en) 2003-09-24
EP1345647A4 (en) 2007-06-20

Similar Documents

Publication Publication Date Title
US6387073B1 (en) Hermetically sealed container with medicament storing and dispensing insert
US8215481B1 (en) Container closure for retaining an additive material
US7870952B2 (en) Packaging the extemporaneous products, particularly medicinal, pharmaceutical, cosmetic products or the like
US8151985B2 (en) Containers for storing at least two substances for subsequent mixing
JP2602614B2 (en) Chemical container
US4950237A (en) Dual chambered mixing and dispensing vial
US3220588A (en) Compartmental dispensing receptacle with accessories
US6571971B1 (en) Hermetically sealed container with pierceable entry port
HU223435B1 (en) Container with a sealed insert, and pump for opening said sealing
JP2000513307A (en) Cap having a blister pack that breaks with opening of the cap
US20100116699A1 (en) Supplement compartment for beverage container
US20120216909A1 (en) Dosing Adapter for Use with Oral Syringe
US9975683B2 (en) Cap with additive chamber and associated packaging unit
US4073406A (en) Container for storing two products separately and dispensing a mixture thereof
EP0542295B1 (en) Drug vessel
US4470505A (en) Method and apparatus for storing, mixing and delivering dental amalgam
WO2002051711A1 (en) An improved closure, capsule and dispensing system
AU700814B2 (en) Container-closure assembly
EP3659938B1 (en) Closure device for a bottle adapted for storing a substance contained in a cavity thereof
CN103171821A (en) Bottle capable of storing solid material
CA2065814A1 (en) Dispenser device
EP0562943A1 (en) Double chambered package
CN203158468U (en) Bottle used for storage of solid materials
JP2023114600A (en) Cap having virgin seal function and attachable to container mouth by screwing-in
EP1278684A1 (en) Container for mixing two components

Legal Events

Date Code Title Description
AS Assignment

Owner name: AUTOMATIC LIQUID PACKAGING, INC., ILLINOIS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:LEO, FRANK N.;REEL/FRAME:011735/0390

Effective date: 20010316

Owner name: WEILER ENGINEERING, INC., ILLINOIS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WEILER, GERHARD H.;REEL/FRAME:011738/0186

Effective date: 20010315

STCF Information on status: patent grant

Free format text: PATENTED CASE

CC Certificate of correction
FPAY Fee payment

Year of fee payment: 4

AS Assignment

Owner name: MORGAN STANLEY SENIOR FUNDING, INC.,NEW YORK

Free format text: SECURITY AGREEMENT;ASSIGNORS:PTS ACQUISITION CORP.;PTS INTERMEDIATE HOLDINGS LLC;CARDINAL HEALTH 400, INC.;AND OTHERS;REEL/FRAME:019323/0302

Effective date: 20070410

Owner name: MORGAN STANLEY SENIOR FUNDING, INC., NEW YORK

Free format text: SECURITY AGREEMENT;ASSIGNORS:PTS ACQUISITION CORP.;PTS INTERMEDIATE HOLDINGS LLC;CARDINAL HEALTH 400, INC.;AND OTHERS;REEL/FRAME:019323/0302

Effective date: 20070410

AS Assignment

Owner name: CATALENT USA WOODSTOCK, INC., NEW JERSEY

Free format text: CHANGE OF NAME;ASSIGNORS:CARDINAL HEALTH 400, INC.;CARDINAL HEALTH 406, LLC;CARDINAL HEALTH 409, INC.;AND OTHERS;REEL/FRAME:019588/0622

Effective date: 20070619

Owner name: CATALENT USA PACKAGING, LLC, NEW JERSEY

Free format text: CHANGE OF NAME;ASSIGNORS:CARDINAL HEALTH 400, INC.;CARDINAL HEALTH 406, LLC;CARDINAL HEALTH 409, INC.;AND OTHERS;REEL/FRAME:019588/0622

Effective date: 20070619

Owner name: CATALENT PHARMA SOLUTIONS, INC., NEW JERSEY

Free format text: CHANGE OF NAME;ASSIGNORS:CARDINAL HEALTH 400, INC.;CARDINAL HEALTH 406, LLC;CARDINAL HEALTH 409, INC.;AND OTHERS;REEL/FRAME:019588/0622

Effective date: 20070619

Owner name: CATALENT USA PAINTBALL, INC., NEW JERSEY

Free format text: CHANGE OF NAME;ASSIGNORS:CARDINAL HEALTH 400, INC.;CARDINAL HEALTH 406, LLC;CARDINAL HEALTH 409, INC.;AND OTHERS;REEL/FRAME:019588/0622

Effective date: 20070619

Owner name: CATALENT PHARMA SOLUTIONS, LLC, NEW JERSEY

Free format text: CHANGE OF NAME;ASSIGNORS:CARDINAL HEALTH 400, INC.;CARDINAL HEALTH 406, LLC;CARDINAL HEALTH 409, INC.;AND OTHERS;REEL/FRAME:019588/0622

Effective date: 20070619

Owner name: CATALENT USA WOODSTOCK, INC.,NEW JERSEY

Free format text: CHANGE OF NAME;ASSIGNORS:CARDINAL HEALTH 400, INC.;CARDINAL HEALTH 406, LLC;CARDINAL HEALTH 409, INC.;AND OTHERS;REEL/FRAME:019588/0622

Effective date: 20070619

Owner name: CATALENT USA PACKAGING, LLC,NEW JERSEY

Free format text: CHANGE OF NAME;ASSIGNORS:CARDINAL HEALTH 400, INC.;CARDINAL HEALTH 406, LLC;CARDINAL HEALTH 409, INC.;AND OTHERS;REEL/FRAME:019588/0622

Effective date: 20070619

Owner name: CATALENT PHARMA SOLUTIONS, INC.,NEW JERSEY

Free format text: CHANGE OF NAME;ASSIGNORS:CARDINAL HEALTH 400, INC.;CARDINAL HEALTH 406, LLC;CARDINAL HEALTH 409, INC.;AND OTHERS;REEL/FRAME:019588/0622

Effective date: 20070619

Owner name: CATALENT USA PAINTBALL, INC.,NEW JERSEY

Free format text: CHANGE OF NAME;ASSIGNORS:CARDINAL HEALTH 400, INC.;CARDINAL HEALTH 406, LLC;CARDINAL HEALTH 409, INC.;AND OTHERS;REEL/FRAME:019588/0622

Effective date: 20070619

Owner name: CATALENT PHARMA SOLUTIONS, LLC,NEW JERSEY

Free format text: CHANGE OF NAME;ASSIGNORS:CARDINAL HEALTH 400, INC.;CARDINAL HEALTH 406, LLC;CARDINAL HEALTH 409, INC.;AND OTHERS;REEL/FRAME:019588/0622

Effective date: 20070619

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12

AS Assignment

Owner name: CATALENT USA WOODSTOCK, INC. (FORMERLY KNOWN AS CARDINAL HEALTH 400, INC.), NEW JERSEY

Free format text: PARTIAL RELEASE OF SECURITY INTEREST;ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:055681/0049

Effective date: 20210322

Owner name: CATALENT PHARMA SOLUTIONS, LLC, NEW JERSEY

Free format text: PARTIAL RELEASE OF SECURITY INTEREST;ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:055681/0049

Effective date: 20210322

Owner name: R.P. SCHERER TECHNOLOGIES, LLC (F/K/A R.P. SCHERER TECHNOLOGIES, INC.), NEW JERSEY

Free format text: PARTIAL RELEASE OF SECURITY INTEREST;ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:055681/0049

Effective date: 20210322